Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Sees Large Increase in Short Interest

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the recipient of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 16,000 shares, an increase of 15.9% from the October 31st total of 13,800 shares. Based on an average daily volume of 255,500 shares, the days-to-cover ratio is presently 0.1 days.

Biodexa Pharmaceuticals Stock Performance

Shares of Biodexa Pharmaceuticals stock traded up $0.12 on Monday, hitting $5.74. The stock had a trading volume of 14,700 shares, compared to its average volume of 149,714. Biodexa Pharmaceuticals has a one year low of $3.50 and a one year high of $103.00.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.